Castle Biosciences, Inc. (CSTL)
NASDAQ: CSTL · Real-Time Price · USD
27.02
-0.10 (-0.37%)
At close: Mar 9, 2026, 4:00 PM EDT
26.50
-0.52 (-1.92%)
After-hours: Mar 9, 2026, 5:43 PM EDT
Castle Biosciences Market Cap
Castle Biosciences has a market cap or net worth of $803.34 million as of March 9, 2026. Its market cap has increased by 9.69% in one year.
Market Cap
803.34M
Enterprise Value
540.85M
1-Year Change
9.69%
Ranking
Category
Stock Price
$27.02
Market Cap Chart
Since July 25, 2019, Castle Biosciences's market cap has increased from $123.05M to $803.34M, an increase of 552.85%. That is a compound annual growth rate of 32.77%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veracyte | 2.69B |
| GeneDx Holdings | 2.58B |
| Neogen | 2.11B |
| GRAIL | 2.03B |
| NeoGenomics | 1.16B |
| CareDx | 916.26M |
| OPKO Health | 895.70M |
| Personalis | 820.31M |